Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	antigen binding	IGHV3-53 IGHV3-49 IGHV3-38 IGHV3-33 IGHV3-30 IGHV3-23 IGHV3-21 IGHV3-20 IGHV3-9 IGHV3-30-5 IGHV3-30-3 IGHV3-38-3 IGHV3-66	1.46e-09	190	146	13	GO:0003823
GeneOntologyBiologicalProcess	immunoglobulin mediated immune response	IGHV3-53 IGHV3-49 IGHV3-38 IGHV3-33 IGHV3-30 IGHV3-23 IGHV3-21 IGHV3-20 IGHV3-9 CRP IGHV3-30-5 IGHV3-30-3 IGHV3-38-3 IGHV3-66	1.12e-09	235	144	14	GO:0016064
GeneOntologyBiologicalProcess	B cell mediated immunity	IGHV3-53 IGHV3-49 IGHV3-38 IGHV3-33 IGHV3-30 IGHV3-23 IGHV3-21 IGHV3-20 IGHV3-9 CRP IGHV3-30-5 IGHV3-30-3 IGHV3-38-3 IGHV3-66	1.82e-09	244	144	14	GO:0019724
GeneOntologyBiologicalProcess	lymphocyte mediated immunity	IGHV3-53 IGHV3-49 IGHV3-38 IGHV3-33 IGHV3-30 IGHV3-23 IGHV3-21 IGHV3-20 IGHV3-9 CRP NCR3 IGHV3-30-5 IGHV3-30-3 IGHV3-38-3 IGHV3-66	6.08e-07	449	144	15	GO:0002449
GeneOntologyBiologicalProcess	leukocyte mediated immunity	IGHV3-53 IGHV3-49 IGHV3-38 IGHV3-33 IGHV3-30 IGHV3-23 IGHV3-21 IGHV3-20 IGHV3-9 BCR CRP NCR3 IGHV3-30-5 IGHV3-30-3 IGHV3-38-3 IGHV3-66	2.82e-06	576	144	16	GO:0002443
GeneOntologyBiologicalProcess	adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains	IGHV3-53 IGHV3-49 IGHV3-38 IGHV3-33 IGHV3-30 IGHV3-23 IGHV3-21 IGHV3-20 IGHV3-9 CRP IGHV3-30-5 IGHV3-30-3 IGHV3-38-3 IGHV3-66	4.56e-06	462	144	14	GO:0002460
GeneOntologyCellularComponent	immunoglobulin complex	IGHV3-53 IGHV3-49 IGHV3-38 IGHV3-33 IGHV3-30 IGHV3-23 IGHV3-21 IGHV3-20 IGHV3-9 IGHV3-30-5 IGHV3-30-3 IGHV3-38-3 IGHV3-66	1.45e-10	166	145	13	GO:0019814
GeneOntologyCellularComponent	CURI complex	RRP7BP RRP7A	1.43e-04	3	145	2	GO:0032545
GeneOntologyCellularComponent	UTP-C complex	RRP7BP RRP7A	1.43e-04	3	145	2	GO:0034456
Domain	WD40_repeat_CS	FBXW10 WDR88 DTL PEX7 GEMIN5 CFAP52 RRP9 HERC1	2.18e-05	164	132	8	IPR019775
Domain	Ig-like_fold	CHL1 MAG MPZ NTRK1 OBSCN CAMTA2 VSIG10 NCR3 FNDC1 IGFBP7 PTPRJ CRLF3 PRKAB2 ALPK3 ALPK2	1.41e-04	706	132	15	IPR013783
Domain	ZF_ZZ_2	MIB2 MIB1 UTRN	2.61e-04	18	132	3	PS50135
Domain	ZF_ZZ_1	MIB2 MIB1 UTRN	2.61e-04	18	132	3	PS01357
Domain	ZZ	MIB2 MIB1 UTRN	2.61e-04	18	132	3	PF00569
Domain	Nebulin	NEBL NEB	2.95e-04	4	132	2	PF00880
Domain	Mib_Herc2	MIB2 MIB1	2.95e-04	4	132	2	IPR010606
Domain	NEBULIN	NEBL NEB	2.95e-04	4	132	2	PS51216
Domain	MIB_HERC2	MIB2 MIB1	2.95e-04	4	132	2	PS51416
Domain	MIB_HERC2	MIB2 MIB1	2.95e-04	4	132	2	PF06701
Domain	NEBU	NEBL NEB	2.95e-04	4	132	2	SM00227
Domain	Nebulin	NEBL NEB	2.95e-04	4	132	2	IPR013998
Domain	Nebulin_repeat	NEBL NEB	2.95e-04	4	132	2	IPR000900
Domain	Znf_ZZ	MIB2 MIB1 UTRN	3.08e-04	19	132	3	IPR000433
Domain	ZnF_ZZ	MIB2 MIB1 UTRN	3.08e-04	19	132	3	SM00291
Domain	G-protein_beta_WD-40_rep	FBXW10 WDR88 PEX7 GEMIN5 RRP9	3.41e-04	85	132	5	IPR020472
Domain	Ig_I-set	CHL1 MAG OBSCN VSIG10 IGFBP7 ALPK3 ALPK2	4.08e-04	190	132	7	IPR013098
Domain	I-set	CHL1 MAG OBSCN VSIG10 IGFBP7 ALPK3 ALPK2	4.08e-04	190	132	7	PF07679
Domain	IP_trans	PITPNM2 PITPNM1	4.89e-04	5	132	2	PF02121
Domain	WD40	FBXW10 WDR88 DTL PEX7 GEMIN5 CFAP52 RRP9 HERC1	5.15e-04	259	132	8	PF00400
Domain	-	PITPNM2 STARD5 PITPNM1	5.51e-04	23	132	3	3.30.530.20
Domain	START-like_dom	PITPNM2 STARD5 PITPNM1	5.51e-04	23	132	3	IPR023393
Domain	WD40	FBXW10 WDR88 DTL PEX7 GEMIN5 CFAP52 RRP9 HERC1	6.44e-04	268	132	8	SM00320
Domain	WD40_repeat	FBXW10 WDR88 DTL PEX7 GEMIN5 CFAP52 RRP9 HERC1	7.09e-04	272	132	8	IPR001680
Domain	Alpha_kinase	ALPK3 ALPK2	7.30e-04	6	132	2	PF02816
Domain	LNS2	PITPNM2 PITPNM1	7.30e-04	6	132	2	IPR013209
Domain	PI_transfer	PITPNM2 PITPNM1	7.30e-04	6	132	2	IPR001666
Domain	LNS2	PITPNM2 PITPNM1	7.30e-04	6	132	2	SM00775
Domain	DDHD	PITPNM2 PITPNM1	7.30e-04	6	132	2	PF02862
Domain	DDHD	PITPNM2 PITPNM1	7.30e-04	6	132	2	PS51043
Domain	MHCK_EF2_kinase	ALPK3 ALPK2	7.30e-04	6	132	2	IPR004166
Domain	DDHD_dom	PITPNM2 PITPNM1	7.30e-04	6	132	2	IPR004177
Domain	LNS2	PITPNM2 PITPNM1	7.30e-04	6	132	2	PF08235
Domain	Hydantoinase/dihydroPyrase	DPYS DPYSL5	7.30e-04	6	132	2	IPR011778
Domain	ALPHA_KINASE	ALPK3 ALPK2	7.30e-04	6	132	2	PS51158
Domain	Alpha_kinase	ALPK3 ALPK2	7.30e-04	6	132	2	SM00811
Domain	LNS2/PITP	PITPNM2 PITPNM1	7.30e-04	6	132	2	IPR031315
Domain	DDHD	PITPNM2 PITPNM1	7.30e-04	6	132	2	SM01127
Domain	WD_REPEATS_1	FBXW10 WDR88 DTL PEX7 GEMIN5 CFAP52 RRP9 HERC1	8.17e-04	278	132	8	PS00678
Domain	IG	CHL1 MAG MPZ NTRK1 OBSCN VSIG10 NCR3 IGFBP7 ALPK3 ALPK2	8.25e-04	421	132	10	SM00409
Domain	Ig_sub	CHL1 MAG MPZ NTRK1 OBSCN VSIG10 NCR3 IGFBP7 ALPK3 ALPK2	8.25e-04	421	132	10	IPR003599
Domain	WD_REPEATS_2	FBXW10 WDR88 DTL PEX7 GEMIN5 CFAP52 RRP9 HERC1	8.37e-04	279	132	8	PS50082
Domain	WD_REPEATS_REGION	FBXW10 WDR88 DTL PEX7 GEMIN5 CFAP52 RRP9 HERC1	8.37e-04	279	132	8	PS50294
Domain	-	CHL1 MAG MPZ NTRK1 OBSCN VSIG10 NCR3 FNDC1 IGFBP7 PTPRJ CRLF3 ALPK3 ALPK2	8.47e-04	663	132	13	2.60.40.10
Domain	ConA-like_dom	TRIM72 PTX4 RNF135 LAMA3 CRP TRIM10 HERC1	9.46e-04	219	132	7	IPR013320
Domain	CH	ACTN3 MICAL3 UTRN IQGAP3	1.16e-03	65	132	4	SM00033
Domain	WD40_repeat_dom	FBXW10 WDR88 DTL PEX7 GEMIN5 CFAP52 RRP9 HERC1	1.25e-03	297	132	8	IPR017986
Domain	-	DPYS DPYSL5	1.35e-03	8	132	2	2.30.40.10
Domain	CH	ACTN3 MICAL3 UTRN IQGAP3	1.52e-03	70	132	4	PF00307
Domain	-	ACTN3 MICAL3 UTRN IQGAP3	1.61e-03	71	132	4	1.10.418.10
Domain	PENTAXIN	PTX4 CRP	1.73e-03	9	132	2	PS00289
Domain	CH	ACTN3 MICAL3 UTRN IQGAP3	1.78e-03	73	132	4	PS50021
Domain	CH-domain	ACTN3 MICAL3 UTRN IQGAP3	1.97e-03	75	132	4	IPR001715
Domain	Amidohydro_1	DPYS DPYSL5	2.15e-03	10	132	2	PF01979
Domain	Metal-dep_hydrolase_composite	DPYS DPYSL5	2.15e-03	10	132	2	IPR011059
Domain	PTX	PTX4 CRP	2.15e-03	10	132	2	SM00159
Domain	-	FBXW10 WDR88 DTL PEX7 GEMIN5 CFAP52 RRP9 HERC1	2.55e-03	333	132	8	2.130.10.10
Domain	IG_LIKE	CHL1 MAG MPZ NTRK1 OBSCN VSIG10 NCR3 IGFBP7 ALPK3 ALPK2	2.58e-03	491	132	10	PS50835
Domain	Pentaxin-related	PTX4 CRP	2.62e-03	11	132	2	IPR001759
Domain	Pentaxin	PTX4 CRP	2.62e-03	11	132	2	PF00354
Domain	Amidohydro-rel	DPYS DPYSL5	2.62e-03	11	132	2	IPR006680
Domain	WD40/YVTN_repeat-like_dom	FBXW10 WDR88 DTL PEX7 GEMIN5 CFAP52 RRP9 HERC1	2.65e-03	335	132	8	IPR015943
Domain	Ig-like_dom	CHL1 MAG MPZ NTRK1 OBSCN VSIG10 NCR3 IGFBP7 ALPK3 ALPK2	3.06e-03	503	132	10	IPR007110
Domain	SPRY	TRIM72 RNF135 TRIM10 HERC1	3.37e-03	87	132	4	SM00449
Domain	AAA	ABCA1 NSF NAIP RUVBL2 ABCC12	3.59e-03	144	132	5	SM00382
Domain	AAA+_ATPase	ABCA1 NSF NAIP RUVBL2 ABCC12	3.59e-03	144	132	5	IPR003593
Domain	SPRY	TRIM72 RNF135 TRIM10 HERC1	4.45e-03	94	132	4	PF00622
Domain	SPRY_dom	TRIM72 RNF135 TRIM10 HERC1	4.45e-03	94	132	4	IPR003877
Domain	B30.2/SPRY	TRIM72 RNF135 TRIM10 HERC1	4.62e-03	95	132	4	IPR001870
Domain	B302_SPRY	TRIM72 RNF135 TRIM10 HERC1	4.62e-03	95	132	4	PS50188
Domain	PRY	TRIM72 RNF135 TRIM10	4.73e-03	48	132	3	SM00589
Domain	PRY	TRIM72 RNF135 TRIM10	4.73e-03	48	132	3	IPR006574
Domain	Beta/gamma_crystallin	CRYBB2 CRYBG3	4.90e-03	15	132	2	IPR001064
Domain	CRYSTALLIN_BETA_GAMMA	CRYBB2 CRYBG3	4.90e-03	15	132	2	PS50915
Domain	Crystall	CRYBB2 CRYBG3	4.90e-03	15	132	2	PF00030
Domain	XTALbg	CRYBB2 CRYBG3	4.90e-03	15	132	2	SM00247
Domain	FKBP_PPIASE	FKBP1A FKBP3	5.58e-03	16	132	2	PS50059
Domain	FKBP_C	FKBP1A FKBP3	5.58e-03	16	132	2	PF00254
Domain	MMR_HSR1	OLA1 ERAL1	6.29e-03	17	132	2	PF01926
Domain	PPIase_FKBP	FKBP1A FKBP3	6.29e-03	17	132	2	IPR023566
Domain	IGc2	CHL1 MAG OBSCN VSIG10 ALPK3 ALPK2	6.54e-03	235	132	6	SM00408
Domain	Ig_sub2	CHL1 MAG OBSCN VSIG10 ALPK3 ALPK2	6.54e-03	235	132	6	IPR003598
Domain	G_crystallin-rel	CRYBB2 CRYBG3	7.04e-03	18	132	2	IPR011024
Pathway	REACTOME_CLASSICAL_ANTIBODY_MEDIATED_COMPLEMENT_ACTIVATION	IGHV3-53 IGHV3-33 IGHV3-30 IGHV3-23 IGHV3-21 IGHV3-20 CRP IGHV3-66	3.40e-10	39	104	8	MM17212
Pathway	REACTOME_INITIAL_TRIGGERING_OF_COMPLEMENT	IGHV3-53 IGHV3-33 IGHV3-30 IGHV3-23 IGHV3-21 IGHV3-20 CRP IGHV3-66	5.25e-09	54	104	8	MM14655
Pathway	REACTOME_CD22_MEDIATED_BCR_REGULATION	IGHV3-53 IGHV3-33 IGHV3-30 IGHV3-23 IGHV3-21 IGHV3-20 IGHV3-66	5.50e-09	35	104	7	MM17219
Pathway	REACTOME_ROLE_OF_LAT2_NTAL_LAB_ON_CALCIUM_MOBILIZATION	IGHV3-53 IGHV3-33 IGHV3-30 IGHV3-23 IGHV3-21 IGHV3-20 IGHV3-66	3.50e-08	45	104	7	MM14912
Pathway	REACTOME_FCGR_ACTIVATION	IGHV3-53 IGHV3-33 IGHV3-30 IGHV3-23 IGHV3-21 IGHV3-20 IGHV3-66	5.57e-08	48	104	7	MM17214
Pathway	REACTOME_ANTIGEN_ACTIVATES_B_CELL_RECEPTOR_BCR_LEADING_TO_GENERATION_OF_SECOND_MESSENGERS	IGHV3-53 IGHV3-33 IGHV3-30 IGHV3-23 IGHV3-21 IGHV3-20 IGHV3-66	1.13e-07	53	104	7	MM15716
Pathway	REACTOME_ROLE_OF_PHOSPHOLIPIDS_IN_PHAGOCYTOSIS	IGHV3-53 IGHV3-33 IGHV3-30 IGHV3-23 IGHV3-21 IGHV3-20 IGHV3-66	1.67e-07	56	104	7	MM14815
Pathway	REACTOME_COMPLEMENT_CASCADE	IGHV3-53 IGHV3-33 IGHV3-30 IGHV3-23 IGHV3-21 IGHV3-20 CRP IGHV3-66	1.83e-07	84	104	8	MM14653
Pathway	REACTOME_FCERI_MEDIATED_CA_2_MOBILIZATION	IGHV3-53 IGHV3-33 IGHV3-30 IGHV3-23 IGHV3-21 IGHV3-20 IGHV3-66	2.14e-07	58	104	7	MM14914
Pathway	REACTOME_BINDING_AND_UPTAKE_OF_LIGANDS_BY_SCAVENGER_RECEPTORS	IGHV3-53 IGHV3-33 IGHV3-30 IGHV3-23 IGHV3-21 IGHV3-20 IGHV3-66	2.72e-07	60	104	7	MM14872
Pathway	REACTOME_FCERI_MEDIATED_MAPK_ACTIVATION	IGHV3-53 IGHV3-33 IGHV3-30 IGHV3-23 IGHV3-21 IGHV3-20 IGHV3-66	2.72e-07	60	104	7	MM14913
Pathway	REACTOME_SIGNALING_BY_THE_B_CELL_RECEPTOR_BCR	IGHV3-53 IGHV3-33 IGHV3-30 IGHV3-23 IGHV3-21 IGHV3-20 PSMA3 FKBP1A IGHV3-66	5.11e-07	131	104	9	MM15717
Pathway	REACTOME_FCERI_MEDIATED_NF_KB_ACTIVATION	IGHV3-53 IGHV3-33 IGHV3-30 IGHV3-23 IGHV3-21 IGHV3-20 PSMA3 IGHV3-66	1.19e-06	107	104	8	MM14915
Pathway	REACTOME_CELL_SURFACE_INTERACTIONS_AT_THE_VASCULAR_WALL	MAG IGHV3-53 IGHV3-33 IGHV3-30 IGHV3-23 IGHV3-21 IGHV3-20 SLC3A2 IGHV3-66	2.46e-06	158	104	9	MM14812
Pathway	REACTOME_FC_EPSILON_RECEPTOR_FCERI_SIGNALING	IGHV3-53 IGHV3-33 IGHV3-30 IGHV3-23 IGHV3-21 IGHV3-20 PSMA3 IGHV3-66	1.48e-05	150	104	8	MM14889
Pathway	REACTOME_FCGAMMA_RECEPTOR_FCGR_DEPENDENT_PHAGOCYTOSIS	IGHV3-53 IGHV3-33 IGHV3-30 IGHV3-23 IGHV3-21 IGHV3-20 IGHV3-66	2.09e-05	114	104	7	MM14814
Pathway	REACTOME_EGR2_AND_SOX10_MEDIATED_INITIATION_OF_SCHWANN_CELL_MYELINATION	MAG MPZ PRX UTRN	5.76e-05	29	104	4	M29808
Pathway	REACTOME_IMMUNOREGULATORY_INTERACTIONS_BETWEEN_A_LYMPHOID_AND_A_NON_LYMPHOID_CELL	IGHV3-53 IGHV3-33 IGHV3-30 IGHV3-23 IGHV3-21 IGHV3-20 IGHV3-66	6.20e-05	135	104	7	MM14781
Pathway	REACTOME_FCGR3A_MEDIATED_IL10_SYNTHESIS	IGHV3-53 AHCYL1 IGHV3-33 IGHV3-30 IGHV3-23 ADCY6	7.13e-05	95	104	6	M29842
Pathway	REACTOME_CREATION_OF_C4_AND_C2_ACTIVATORS	IGHV3-53 IGHV3-33 IGHV3-30 IGHV3-23 CRP	1.76e-04	71	104	5	M1078
Pathway	REACTOME_SIGNALING_BY_THE_B_CELL_RECEPTOR_BCR	IGHV3-53 AHCYL1 IGHV3-33 IGHV3-30 IGHV3-23 PSMA3 FKBP1A	2.26e-04	166	104	7	M608
Pathway	REACTOME_INITIAL_TRIGGERING_OF_COMPLEMENT	IGHV3-53 IGHV3-33 IGHV3-30 IGHV3-23 CRP	3.08e-04	80	104	5	M6121
Pathway	REACTOME_ROLE_OF_PHOSPHOLIPIDS_IN_PHAGOCYTOSIS	IGHV3-53 AHCYL1 IGHV3-33 IGHV3-30 IGHV3-23	3.45e-04	82	104	5	M27110
Pathway	REACTOME_ANTIGEN_ACTIVATES_B_CELL_RECEPTOR_BCR_LEADING_TO_GENERATION_OF_SECOND_MESSENGERS	IGHV3-53 AHCYL1 IGHV3-33 IGHV3-30 IGHV3-23	4.30e-04	86	104	5	M601
Pathway	REACTOME_FCERI_MEDIATED_CA_2_MOBILIZATION	IGHV3-53 AHCYL1 IGHV3-33 IGHV3-30 IGHV3-23	4.30e-04	86	104	5	M27206
Pathway	REACTOME_ANTI_INFLAMMATORY_RESPONSE_FAVOURING_LEISHMANIA_PARASITE_INFECTION	IGHV3-53 AHCYL1 IGHV3-33 IGHV3-30 IGHV3-23 ADCY6	4.67e-04	134	104	6	M29840
Pathway	REACTOME_SYNTHESIS_OF_PI	PITPNM2 PITPNM1	5.31e-04	5	104	2	M26962
Pathway	REACTOME_SYNTHESIS_OF_PI	PITPNM2 PITPNM1	5.31e-04	5	104	2	MM14587
Pathway	REACTOME_ADAPTIVE_IMMUNE_SYSTEM	IGHV3-53 IGHV3-33 FBXW10 IGHV3-30 IGHV3-23 IGHV3-21 IGHV3-20 PSMA3 MIB2 PTPRJ HERC1 FKBP1A DYNC1LI2 IGHV3-66	7.96e-04	719	104	14	MM14540
Pathway	REACTOME_CD22_MEDIATED_BCR_REGULATION	IGHV3-53 IGHV3-33 IGHV3-30 IGHV3-23	1.06e-03	61	104	4	M27581
Pathway	REACTOME_LEISHMANIA_INFECTION	IGHV3-53 AHCYL1 IGHV3-33 IGHV3-30 IGHV3-23 ADCY6 SUGT1	1.18e-03	219	104	7	M29836
Pubmed	1.3 A X-ray structure of an antibody Fv fragment used for induced membrane-protein crystallization.	IGHV3-53 IGHV3-33 IGHV3-30 IGHV3-23 IGHV3-21 IGHV3-20 IGHV3-66	1.30e-13	15	147	7	12657787
Pubmed	Early onset of somatic mutation in immunoglobulin VH genes during the primary immune response.	IGHV3-53 IGHV3-33 IGHV3-30 IGHV3-23 IGHV3-21 IGHV3-20 IGHV3-66	3.37e-12	22	147	7	2499654
Pubmed	The complete nucleotide sequence of the human immunoglobulin heavy chain variable region locus.	IGHV3-53 IGHV3-49 IGHV3-38 IGHV3-33 IGHV3-30 IGHV3-21 IGHV3-20 IGHV3-9 IGHV3-66	1.96e-10	91	147	9	9841928
Pubmed	IMGT/GENE-DB: a comprehensive database for human and mouse immunoglobulin and T cell receptor genes.	IGHV3-53 IGHV3-49 IGHV3-33 IGHV3-30 IGHV3-23 IGHV3-21 IGHV3-20 IGHV3-66	1.38e-09	77	147	8	15608191
Pubmed	Structure and physical map of 64 variable segments in the 3'0.8-megabase region of the human immunoglobulin heavy-chain locus.	IGHV3-53 IGHV3-49 IGHV3-38 IGHV3-23 IGHV3-20 IGHV3-9	1.50e-08	39	147	6	8490662
Pubmed	KCTD13-mediated ubiquitination and degradation of GluN1 regulates excitatory synaptic transmission and seizure susceptibility.	MAG GPD2 PITPNM2 IGHV3-49 AHCYL1 SYT3 ACAT1 NSF ACO2 RBP3 DPYSL5 GEMIN5 ZC3HC1 YTHDC2 ACTN3 OLA1 BCR SLC3A2 EIF3CL PITPNM1 CCT5 MICAL3 UTRN	3.78e-08	1431	147	23	37142655
Pubmed	Identifications of novel host cell factors that interact with the receptor-binding domain of the SARS-CoV-2 spike protein.	AHCYL1 C15orf39 YTHDC2 MIB2 BCR RUVBL2 ADCY6 DDOST CLPTM1L SMG8 MICAL3 TIMM29 CRYBG3 CLEC16A IQGAP3	1.23e-07	650	147	15	38777146
Pubmed	Neuron-specific protein network mapping of autism risk genes identifies shared biological mechanisms and disease-relevant pathologies.	PITPNM2 AHCYL1 ACACB ACAT1 ACO2 ADGRB1 MIB2 BCR RUVBL2 HNRNPH2 SLC3A2 EIF3CL PITPNM1 SEPTIN3 SUGT1 CCT5 CRYBG3 CLEC16A	1.66e-06	1139	147	18	36417873
Pubmed	Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation.	GPD2 ACAT1 NSF ACO2 PSMA3 CARS1 GEMIN5 YTHDC2 OLA1 RUVBL2 DDOST SLC3A2 EIF3CL CLPTM1L CCT5 ERAL1 RRP9 RRP7A IQGAP3 FKBP3	2.58e-06	1425	147	20	30948266
Pubmed	Myopalladin, a novel 145-kilodalton sarcomeric protein with multiple roles in Z-disc and I-band protein assemblies.	NEBL ACTN3 NEB	4.08e-06	8	147	3	11309420
Pubmed	IKK-Mediated Regulation of the COP9 Signalosome via Phosphorylation of CSN5.	AHCYL1 TNPO2 DTL GEMIN5 YTHDC2 OLA1 SLC3A2 SUGT1	4.89e-06	221	147	8	31950832
Pubmed	Large-scale proteomics and phosphoproteomics of urinary exosomes.	DPYS NEBL ACAT1 CDHR2 PSMA3 OLA1 TECTA NEB BCR SLC3A2 ADH5 PTPN13 PTPRJ CCT5 NAPRT UTRN	6.84e-06	1016	147	16	19056867
Pubmed	The ubiquitin-dependent ATPase p97 removes cytotoxic trapped PARP1 from chromatin.	GPD2 YTHDC2 OLA1 DDOST SLC3A2 PTPN13 POLR1B TIMM29 IQGAP3 IGHV3-66	8.49e-06	400	147	10	35013556
Pubmed	Loss of ER retention motif of AGR2 can impact mTORC signaling and promote cancer metastasis.	GPD2 ACAT1 ACO2 PSMA3 OLA1 RUVBL2 DDOST SLC3A2 ADH5 CCT5 UTRN IQGAP3 FKBP3 AHNAK2	9.08e-06	807	147	14	30575818
Pubmed	BPA modulates the WDR5/TET2 complex to regulate ERβ expression in eutopic endometrium and drives the development of endometriosis.	ACAT1 ACO2 OLA1 RUVBL2 DDOST HNRNPH2 ZCCHC3 SLC3A2 CCT5 RRP9 UTRN FKBP3 DYNC1LI2	1.11e-05	711	147	13	33022573
Pubmed	Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function.	AHCYL1 DIS3L2 ACAT1 ACO2 PSMA3 GEMIN5 RUVBL2 DDOST HNRNPH2 SLC3A2 SMG8 SUGT1 CCT5 ERAL1 MIB1 POLR1B UTRN AHNAK2	1.75e-05	1353	147	18	29467282
Pubmed	CD148 tyrosine phosphatase promotes cadherin cell adhesion.	PTPRJ CDH1	1.77e-05	2	147	2	25386896
Pubmed	Genetic risk for myocardial infarction in Japanese individuals with or without chronic kidney disease.	LAMA3 CLEC16A	1.77e-05	2	147	2	20372818
Pubmed	Targeted disruption of Mib2 causes exencephaly with a variable penetrance.	MIB2 MIB1	1.77e-05	2	147	2	17987667
Pubmed	A gene polymorphism in acetyl-coenzyme A carboxylase beta may be associated with the C-reactive protein level in a prediabetic and diabetic population.	ACACB CRP	1.77e-05	2	147	2	21553357
Pubmed	Missense polymorphisms of PTPRJ and PTPN13 genes affect susceptibility to a variety of human cancers.	PTPN13 PTPRJ	1.77e-05	2	147	2	19672627
Pubmed	Contribution of the LIM domain and nebulin-repeats to the interaction of Lasp-2 with actin filaments and focal adhesions.	NEBL NEB	1.77e-05	2	147	2	19851499
Pubmed	Maintenance of type 2 glycolytic myofibers with age by Mib1-Actn3 axis.	ACTN3 MIB1	1.77e-05	2	147	2	33637766
Pubmed	Evaluation of Adenosine Triphosphate-Binding Cassette Transporter A1 (ABCA1) R219K and C-Reactive Protein Gene (CRP) +1059G/C Gene Polymorphisms in Susceptibility to Coronary Heart Disease.	ABCA1 CRP	1.77e-05	2	147	2	27560308
Pubmed	Validating Fluorescent Chrnb4.EGFP Mouse Models for the Study of Cone Photoreceptor Degeneration.	PDE6C GNAT2	1.77e-05	2	147	2	32879784
Pubmed	NR4A2 haploinsufficiency is associated with intellectual disability and autism spectrum disorder.	GPD2 NR4A2	1.77e-05	2	147	2	29770430
Pubmed	Targeting SLC3A2 subunit of system XC- is essential for m6A reader YTHDC2 to be an endogenous ferroptosis inducer in lung adenocarcinoma.	YTHDC2 SLC3A2	1.77e-05	2	147	2	33785413
Pubmed	A High-Density Human Mitochondrial Proximity Interaction Network.	GPD2 ACAT1 ACO2 COQ5 PSMA3 DTL YTHDC2 DDOST ZCCHC3 CLPTM1L SUGT1 CCT5 ERAL1 RRP9 MIB1 TIMM29 CRYBG3 HERC1 AHNAK2	1.91e-05	1496	147	19	32877691
Pubmed	The Deubiquitinating Enzyme USP48 Interacts with the Retinal Degeneration-Associated Proteins UNC119a and ARL3.	PDE6C ACAT1 NSF ACO2 RBP3 DPYSL5 HNRNPH2 SLC3A2 CRYBB2 CCT5 GNAT2	2.47e-05	552	147	11	36293380
Pubmed	Phenotypic and Interaction Profiling of the Human Phosphatases Identifies Diverse Mitotic Regulators.	GPD2 CCDC8 DDOST SLC3A2 ADH5 PTPN13 SUGT1 PTPRJ CCT5 CRLF3 MIB1 MICAL3 CRYBG3 HERC1 UTRN	4.09e-05	1049	147	15	27880917
Pubmed	BioID-based intact cell interactome of the Kv1.3 potassium channel identifies a Kv1.3-STAT3-p53 cellular signaling pathway.	GPD2 AHCYL1 NSF YTHDC2 RUVBL2 DDOST SLC3A2 CLPTM1L PTPN13 CCT5 MICAL3 CRYBG3	5.08e-05	708	147	12	39231216
Pubmed	Pitpnm1 is expressed in hair cells during development but is not required for hearing.	PITPNM2 PITPNM1	5.31e-05	3	147	2	23820044
Pubmed	Replication of lung cancer susceptibility loci at chromosomes 15q25, 5p15, and 6p21: a pooled analysis from the International Lung Cancer Consortium.	CHRNA5 CLPTM1L	5.31e-05	3	147	2	20548021
Pubmed	Lessons from genetic knockout mice deficient in neural recognition molecules.	MAG MPZ	5.31e-05	3	147	2	7524110
Pubmed	RUVBL1 ubiquitination by DTL promotes RUVBL1/2-β-catenin-mediated transcriptional regulation of NHEJ pathway and enhances radiation resistance in breast cancer.	DTL RUVBL2	5.31e-05	3	147	2	38609375
Pubmed	Sequence of the alpha subunit of photoreceptor G protein: homologies between transducin, ras, and elongation factors.	MAG GNAT2	5.31e-05	3	147	2	3856323
Pubmed	Mind bomb-2 is an E3 ligase for Notch ligand.	MIB2 MIB1	5.31e-05	3	147	2	15824097
Pubmed	Self-regulated alternative splicing at the AHNAK locus.	PRX AHNAK2	5.31e-05	3	147	2	21940993
Pubmed	Conduction block in PMP22 deficiency.	MAG MPZ	5.31e-05	3	147	2	20071523
Pubmed	Cloning and characterization of a novel variant (mM-rdgBbeta1) of mouse M-rdgBs, mammalian homologs of Drosophila retinal degeneration B gene proteins, and its mRNA localization in mouse brain in comparison with other M-rdgBs.	PITPNM2 PITPNM1	5.31e-05	3	147	2	12562526
Pubmed	The adhesion-GPCR BAI1 shapes dendritic arbors via Bcr-mediated RhoA activation causing late growth arrest.	ADGRB1 BCR	5.31e-05	3	147	2	31461398
Pubmed	P0 protein is required for and can induce formation of schmidt-lantermann incisures in myelin internodes.	MAG MPZ	5.31e-05	3	147	2	18614675
Pubmed	Subtle roles of neural cell adhesion molecule and myelin-associated glycoprotein during Schwann cell spiralling in P0-deficient mice.	MAG MPZ	5.31e-05	3	147	2	10457367
Pubmed	The E3 ubiquitin ligase MIB1 suppresses breast cancer cell migration through regulating CTNND1 protein level.	MIB1 CDH1	5.31e-05	3	147	2	37209565
Pubmed	Laryngeal neuropathy of Charcot-Marie-Tooth disease: further observations and novel mutations associated with vocal fold paresis.	MPZ PRX	5.31e-05	3	147	2	19950375
Pubmed	Homophilic binding of the neural cell adhesion molecule CHL1 regulates development of ventral midbrain dopaminergic pathways.	CHL1 NR4A2	5.31e-05	3	147	2	28839197
Pubmed	Chromosomal localization, genomic organization and evolution of the genes encoding human phosphatidylinositol transfer protein membrane-associated (PITPNM) 1, 2 and 3.	PITPNM2 PITPNM1	5.31e-05	3	147	2	15627748
Pubmed	The close homologue of the neural adhesion molecule L1 (CHL1): patterns of expression and promotion of neurite outgrowth by heterophilic interactions.	CHL1 MAG	5.31e-05	3	147	2	10103075
Pubmed	A Degradation Motif in STAU1 Defines a Novel Family of Proteins Involved in Inflammation.	ACAT1 GEMIN5 YTHDC2 OLA1 BCR RUVBL2 ZCCHC3 PTPN13 CCT5 POLR1B FKBP3 AHNAK2	6.28e-05	724	147	12	36232890
Pubmed	Integrin-linked kinase is required for radial sorting of axons and Schwann cell remyelination in the peripheral nervous system.	MAG MPZ PRX	6.82e-05	19	147	3	19349584
Pubmed	In silico APC/C substrate discovery reveals cell cycle-dependent degradation of UHRF1 and other chromatin regulators.	AHCYL1 CCDC8 PSMA3 YTHDC2 RUVBL2 DDOST HNRNPH2 ZCCHC3 SLC3A2 EIF3CL FNDC1 CCT5 ERAL1 IQGAP3	6.84e-05	971	147	14	33306668
Pubmed	A dual-activity topoisomerase complex regulates mRNA translation and turnover.	PITPNM2 PIEZO1 OBSCN C15orf39 GEMIN5 MIB2 BCR C2CD2 SLC38A10 CANT1 NAPRT MICAL3 HERC1 IQGAP3 AHNAK2	7.33e-05	1105	147	15	35748872
Pubmed	Proximity interactions of the ubiquitin ligase Mind bomb 1 reveal a role in regulation of epithelial polarity complex proteins.	GEMIN5 YTHDC2 ZCCHC3 EIF3CL PTPN13 MIB1	8.65e-05	169	147	6	31462741
Pubmed	SERBP1 Promotes Stress Granule Clearance by Regulating 26S Proteasome Activity and G3BP1 Ubiquitination and Protects Male Germ Cells from Thermostimuli Damage.	GPD2 AHCYL1 ACAT1 NSF PSMA3 CARS1 ZC3HC1 RUVBL2 SLC3A2 ADH5 CLPTM1L SUGT1 CCT5	9.64e-05	878	147	13	37223481
Pubmed	Bex1 is involved in the regeneration of axons after injury.	MAG MPZ	1.06e-04	4	147	2	20731761
Pubmed	AMP kinase and malonyl-CoA: targets for therapy of the metabolic syndrome.	ACACB PRKAB2	1.06e-04	4	147	2	15060529
Pubmed	Single phosphorylation sites in Acc1 and Acc2 regulate lipid homeostasis and the insulin-sensitizing effects of metformin.	ACACB PRKAB2	1.06e-04	4	147	2	24185692
Pubmed	Retinal output changes qualitatively with every change in ambient illuminance.	PDE6C GNAT2	1.06e-04	4	147	2	25485757
Pubmed	Structure of a multifunctional protein. Mammalian phosphatidylinositol transfer protein complexed with phosphatidylcholine.	PITPNM2 PITPNM1	1.06e-04	4	147	2	11104777
Pubmed	Reduced ABCA1-mediated cholesterol efflux and accelerated atherosclerosis in apolipoprotein E-deficient mice lacking macrophage-derived ACAT1.	ABCA1 ACAT1	1.06e-04	4	147	2	15851589
Pubmed	Molecular genetics of achromatopsia in Newfoundland reveal genetic heterogeneity, founder effects and the first cases of Jalili syndrome in North America.	PDE6C GNAT2	1.06e-04	4	147	2	23362848
Pubmed	Structural requirements for interaction of peroxisomal targeting signal 2 and its receptor PEX7.	ACAT1 PEX7	1.06e-04	4	147	2	22057399
Pubmed	Identification of Xin-repeat proteins as novel ligands of the SH3 domains of nebulin and nebulette and analysis of their interaction during myofibril formation and remodeling.	NEBL NEB	1.06e-04	4	147	2	23985323
Pubmed	Association of genetic variants in SEMA3F, CLEC16A, LAMA3, and PCSK2 with myocardial infarction in Japanese individuals.	LAMA3 CLEC16A	1.06e-04	4	147	2	20036365
Pubmed	Neuronal ER-plasma membrane junctions organized by Kv2-VAP pairing recruit Nir proteins and affect phosphoinositide homeostasis.	PITPNM2 PITPNM1	1.06e-04	4	147	2	31594866
Pubmed	Age-related changes in myelin morphology, electrophysiological property and myelin-associated protein expression of mouse sciatic nerves.	MAG MPZ	1.06e-04	4	147	2	21824506
Pubmed	Identification of a novel family of targets of PYK2 related to Drosophila retinal degeneration B (rdgB) protein.	PITPNM2 PITPNM1	1.06e-04	4	147	2	10022914
Pubmed	Clinical utility gene card for: achromatopsia.	PDE6C GNAT2	1.06e-04	4	147	2	21267001
Pubmed	Krox-20 controls myelination in the peripheral nervous system.	MAG MPZ	1.06e-04	4	147	2	7935840
Pubmed	Identifying biological pathways that underlie primordial short stature using network analysis.	GPD2 CCDC8 ACAT1 NSF YTHDC2 OLA1 RUVBL2 DDOST HNRNPH2 SLC3A2 CCT5 ERAL1 RRP9 UTRN	1.19e-04	1024	147	14	24711643
Pubmed	Complementary proteomics strategies capture an ataxin-1 interactome in Neuro-2a cells.	ACACB ACAT1 NSF ACO2 DPYSL5 ACTN3 RUVBL2 HNRNPH2 SLC3A2 EIF3CL CCT5	1.30e-04	665	147	11	30457570
Pubmed	Mapping the NPHP-JBTS-MKS protein network reveals ciliopathy disease genes and pathways.	MAG PSMA3 OBSCN RUVBL2 HNRNPH2 PITPNM1 PTPN13 PEDS1 IQGAP3 KLHL4	1.52e-04	564	147	10	21565611
Pubmed	BAP1 regulation of the key adaptor protein NCoR1 is critical for γ-globin gene repression.	ACACB ACAT1 NSF ACO2 GEMIN5 RUVBL2 DDOST HNRNPH2 ZCCHC3 EIF3CL FAM111A CCT5 RRP9 MIB1 RRP7A POLR1B	1.52e-04	1318	147	16	30463901
Pubmed	Disruption of Krox20-Nab interaction in the mouse leads to peripheral neuropathy with biphasic evolution.	MAG MPZ PRX	1.59e-04	25	147	3	18524893
Pubmed	New roles for the de-ubiquitylating enzyme OTUD4 in an RNA-protein network and RNA granules.	MAG DIS3L2 PSMA3 MIB2 HNRNPH2 PRKAB2 MIB1 SERAC1 TIMM29	1.63e-04	462	147	9	31138677
Pubmed	Multilevel proteomics reveals host perturbations by SARS-CoV-2 and SARS-CoV.	GPD2 AHCYL1 ACAT1 NSF ACO2 PCDHA4 C2CD2 ADCY6 SUGT1 PTPRJ CANT1 HERC1 FKBP1A FKBP3	1.72e-04	1061	147	14	33845483
Pubmed	Intestinal brush border assembly driven by protocadherin-based intermicrovillar adhesion.	CDHR2 CDH1	1.76e-04	5	147	2	24725409
Pubmed	Role of 5p15.33 (TERT-CLPTM1L), 6p21.33 and 15q25.1 (CHRNA5-CHRNA3) variation and lung cancer risk in never-smokers.	CHRNA5 CLPTM1L	1.76e-04	5	147	2	19955392
Pubmed	Specific disruption of a schwann cell dystrophin-related protein complex in a demyelinating neuropathy.	PRX UTRN	1.76e-04	5	147	2	11430802
Pubmed	The molecular basis of the neuropathies of mouse and human.	MAG MPZ	1.76e-04	5	147	2	7568894
Pubmed	Genetic variations and treatments that affect the lifespan of the NPC1 mouse.	ABCA1 ST3GAL5	1.76e-04	5	147	2	18077828
Pubmed	Hsp90 cochaperone Aha1 downregulation rescues misfolding of CFTR in cystic fibrosis.	DTL BCR RUVBL2 SEPTIN3 CCT5 CDH1	1.89e-04	195	147	6	17110338
Pubmed	Direct interaction between hnRNP-M and CDC5L/PLRG1 proteins affects alternative splice site choice.	NSF ZC3HC1 YTHDC2 SNUPN OLA1 RUVBL2 SUGT1 CCT5 ERAL1 DYNC1LI2	1.95e-04	582	147	10	20467437
Pubmed	The RNA-mediated estrogen receptor α interactome of hormone-dependent human breast cancer cell nuclei.	NEBL NSF PIEZO1 GEMIN5 YTHDC2 OLA1 SLC3A2 CLPTM1L PTPN13 SEPTIN3 CCT5 RRP9 RRP7A POLR1B UTRN IQGAP3 FKBP3	2.07e-04	1497	147	17	31527615
Pubmed	Construction of long-transcript enriched cDNA libraries from submicrogram amounts of total RNAs by a universal PCR amplification method.	KIF13B CHAC2 DTL OBSCN GEMIN5 CAMTA2 ADH5 PTPN13 CANT1 ERAL1 HERC1 CDH1 UTRN DYNC1LI2	2.15e-04	1084	147	14	11544199
Pubmed	Integrating genetic and network analysis to characterize genes related to mouse weight.	GPD2 PDE6C NEB	2.49e-04	29	147	3	16934000
Pubmed	Genome-wide association of lipid-lowering response to statins in combined study populations.	CHL1 GPD2 KIF13B NR4A2	2.52e-04	72	147	4	20339536
Pubmed	Genome-wide association scan of tag SNPs identifies a susceptibility locus for lung cancer at 15q25.1.	CHRNA5 CRP	2.63e-04	6	147	2	18385676
Pubmed	Achromatopsia	PDE6C GNAT2	2.63e-04	6	147	2	20301591
Pubmed	Molecular characterization of CRMP5, a novel member of the collapsin response mediator protein family.	DPYS DPYSL5	2.63e-04	6	147	2	10956643
Pubmed	A genome-wide association study of lung cancer identifies a region of chromosome 5p15 associated with risk for adenocarcinoma.	CHRNA5 CLPTM1L	2.63e-04	6	147	2	19836008
Pubmed	Comparison of the human immune response to conjugate and polysaccharide pneumococcal vaccination using a reconstituted SCID mouse model.	IGHV3-49 IGHV3-30	2.63e-04	6	147	2	16860443
Pubmed	The nuclear receptor Nor-1 is essential for proliferation of the semicircular canals of the mouse inner ear.	NR4A2 CDH1	2.63e-04	6	147	2	11784868
Pubmed	Molecular characterization and gene content of breakpoint boundaries in patients with neurofibromatosis type 1 with 17q11.2 microdeletions.	RNF135 CRLF3	2.63e-04	6	147	2	11468690
Pubmed	Regulation of RUVBL1-RUVBL2 AAA-ATPases by the nonsense-mediated mRNA decay factor DHX34, as evidenced by Cryo-EM.	RUVBL2 SMG8	2.63e-04	6	147	2	33205750
Pubmed	Drp2 and periaxin form Cajal bands with dystroglycan but have distinct roles in Schwann cell growth.	PRX UTRN	2.63e-04	6	147	2	22764250
Pubmed	Alpha-kinases: a new class of protein kinases with a novel catalytic domain.	ALPK3 ALPK2	2.63e-04	6	147	2	10021370
Pubmed	Bcr-Abl-induced tyrosine phosphorylation of Emi1 to stabilize Skp2 protein via inhibition of ubiquitination in chronic myeloid leukemia cells.	BCR CDH1	2.63e-04	6	147	2	20717963
Pubmed	A Human Tyrosine Phosphatase Interactome Mapped by Proteomic Profiling.	ASNSD1 AHCYL1 NSF PSMA3 DTL DPYSL5 YTHDC2 BCR DDOST SLC3A2 CCT5 ERAL1 UTRN	2.65e-04	974	147	13	28675297
Pubmed	Blocking an N-terminal acetylation-dependent protein interaction inhibits an E3 ligase.	ACAT1 NSF PSMA3 DTL RUVBL2 EIF3CL SUGT1 CCT5 CLEC16A	2.71e-04	495	147	9	28581483
Cytoband	14q32.33	IGHV3-53 IGHV3-49 IGHV3-38 IGHV3-33 IGHV3-30 IGHV3-23 IGHV3-21 IGHV3-20 IGHV3-9 IGHV3-30-5 IGHV3-30-3 IGHV3-38-3 AHNAK2 IGHV3-66	3.04e-14	228	148	14	14q32.33
Cytoband	Ensembl 112 genes in cytogenetic band chr14q32	IGHV3-53 IGHV3-49 IGHV3-38 IGHV3-33 IGHV3-30 IGHV3-23 IGHV3-21 IGHV3-20 AHNAK2 IGHV3-66	1.67e-05	566	148	10	chr14q32
Cytoband	22q13.2	RRP7BP ACO2 SEPTIN3 RRP7A	4.39e-05	60	148	4	22q13.2
GeneFamily	Immunoglobulin heavy locus at 14q32.33	IGHV3-53 IGHV3-49 IGHV3-38 IGHV3-33 IGHV3-30 IGHV3-23 IGHV3-21 IGHV3-20 IGHV3-9 IGHV3-30-5 IGHV3-30-3 IGHV3-38-3 IGHV3-66	7.91e-11	187	107	13	349
GeneFamily	Blood group antigens\|CD molecules\|I-set domain containing\|Immunoglobulin like domain containing	CHL1 MAG OBSCN VSIG10 IGFBP7 ALPK3 ALPK2	4.82e-05	161	107	7	593
GeneFamily	Zinc fingers ZZ-type\|Lysine acetyltransferases	MIB2 MIB1 UTRN	1.54e-04	18	107	3	91
GeneFamily	WD repeat domain containing	FBXW10 WDR88 DTL PEX7 GEMIN5 CFAP52 RRP9 HERC1	1.65e-04	262	107	8	362
GeneFamily	Phosphatidylinositol transfer proteins	PITPNM2 PITPNM1	5.12e-04	6	107	2	1151
GeneFamily	Fibronectin type III domain containing	CHL1 OBSCN FNDC1 PTPRJ CRLF3	2.62e-03	160	107	5	555
Coexpression	RASHI_RESPONSE_TO_IONIZING_RADIATION_6	IGHV3-53 IGHV3-33 IGHV3-30 IGHV3-23 IGHV3-21 IGHV3-20 ZCCHC3 SUGT1 RRP7A IGHV3-66	2.81e-09	132	142	10	MM996
Coexpression	XU_CREBBP_TARGETS_DN	IGHV3-53 IGHV3-33 IGHV3-30 IGHV3-23 IGHV3-21 IGHV3-20 IGHV3-66	2.19e-08	56	142	7	MM642
Coexpression	YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_6	IGHV3-53 IGHV3-33 IGHV3-30 IGHV3-23 IGHV3-21 IGHV3-20 IGHV3-66	1.42e-06	102	142	7	MM872
Coexpression	SCHMIDT_POR_TARGETS_IN_LIMB_BUD_DN	ABCA1 NAIP CHRNA5	8.55e-06	8	142	3	MM933
Coexpression	SCHMIDT_POR_TARGETS_IN_LIMB_BUD_DN	ABCA1 NAIP CHRNA5	8.55e-06	8	142	3	M2384
Coexpression	DESCARTES_FETAL_MUSCLE_SCHWANN_CELLS	CHL1 MAG MPZ TMEM132B PRX CDH1	4.14e-05	116	142	6	M40251
CoexpressionAtlas	Pluripotent Stem Cells-reprogram_NA_vs_Pluripotent Stem Cells-reprogram_OSK-l-N-p53KD-Confounder_removed-fold2.0_adjp0.05	DPYSL5 EIF3CL NAPRT MIB1 ALPK3	1.63e-05	49	138	5	PCBC_ratio_ESC_vs_iPSC_method-OSK-l-N-p53KD_cfr-2X-p05
CoexpressionAtlas	AravindRamakr_StemCell_from_inducedPluripotentialStemCells_derived from_from_fibroblast_top-relative-expression-ranked_1000_k-means-cluster#5	IGHV3-33 IGHV3-30 IGHV3-23 IGHV3-21 IGHV3-9 CDHR2 DPYSL5 IGHV3-66	2.67e-05	183	138	8	Arv_SC_fibroblast_1000_K5
CoexpressionAtlas	dev gonad_e12.5_M_InterstitLeydig_MafB_k-means-cluster#3_top-relative-expression-ranked_1000	ABCA1 PIEZO1 FAM111A IGFBP7 KLHL4	5.60e-05	63	138	5	gudmap_dev gonad_e12.5_M_InterstitLeydig_MafB_k3_1000
ToppCell	COVID_vent-Lymphocytic-Plasma_cell-IgM_Plasmablast\|COVID_vent / Disease condition, Lineage, Cell class and subclass	IGHV3-53 IGHV3-38 IGHV3-33 IGHV3-30 IGHV3-23 IGHV3-21 IGHV3-20 IGHV3-9 CLPTM1L IGHV3-66	9.05e-10	196	144	10	026a06d8d2089806823e6f6453d3ede84ae93bc6
ToppCell	Parenchymal-10x5prime-Immune_Lymphocytic-B-B_plasma-B_plasma_IgA\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	IGHV3-53 IGHV3-49 IGHV3-38 IGHV3-33 IGHV3-30 IGHV3-23 IGHV3-21 IGHV3-20 IGHV3-66	1.41e-08	193	144	9	34f6c13884fdf7f8a87f942fcb36a58cfac3f65d
ToppCell	Parenchymal-10x5prime-Immune_Lymphocytic-B-B_plasma\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	IGHV3-53 IGHV3-49 IGHV3-38 IGHV3-33 IGHV3-30 IGHV3-23 IGHV3-21 IGHV3-20 IGHV3-66	1.47e-08	194	144	9	6ef4aeb8d8e35e4df58ff2a8256caa2113291de9
ToppCell	COVID_non-vent-Lymphocytic-Plasma_cell\|COVID_non-vent / Disease condition, Lineage, Cell class and subclass	IGHV3-53 IGHV3-33 IGHV3-30 IGHV3-23 IGHV3-21 IGHV3-20 DDOST CLPTM1L IGHV3-66	1.68e-08	197	144	9	1e63879633f20646e44873ae6b662f6faf4806fd
ToppCell	COVID_vent-Lymphocytic-Plasma_cell\|COVID_vent / Disease condition, Lineage, Cell class and subclass	IGHV3-53 IGHV3-33 IGHV3-30 IGHV3-23 IGHV3-21 IGHV3-20 IGHV3-9 DDOST CLPTM1L	1.76e-08	198	144	9	e84c5f712e1dea548d0e2aba6625598f9671d3a0
ToppCell	367C-Lymphocytic-Plasma_cell-\|367C / Donor, Lineage, Cell class and subclass (all cells)	IGHV3-53 IGHV3-49 IGHV3-33 IGHV3-30 IGHV3-23 IGHV3-21 IGHV3-20 IGHV3-66	7.46e-08	167	144	8	f2185eb72f0137136f6d71af2a70168fded6c940
ToppCell	367C-Lymphocytic-Plasma_cell\|367C / Donor, Lineage, Cell class and subclass (all cells)	IGHV3-53 IGHV3-49 IGHV3-33 IGHV3-30 IGHV3-23 IGHV3-21 IGHV3-20 IGHV3-66	7.46e-08	167	144	8	5e768cf24699893e05d1bcb1c92dba2336943a64
ToppCell	5'-Parenchyma_lung-Immune_Lymphocytic-Lymphocytic_B-plasma_cell-Plasma_cells-Plasma_cells_L.1.7.0.1\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	IGHV3-53 IGHV3-49 IGHV3-33 IGHV3-30 IGHV3-23 IGHV3-21 IGHV3-20 IGHV3-66	1.39e-07	181	144	8	e47664a264a2c37390d1668ce04eef2e0172f4cb
ToppCell	Mild_COVID-19-B_cell\|Mild_COVID-19 / Disease group,lineage and cell class （2021.01.30）	IGHV3-53 IGHV3-33 IGHV3-30 IGHV3-23 IGHV3-21 IGHV3-20 NCR3 IGHV3-66	1.51e-07	183	144	8	dea119e2988e954475f557f0bbe12556a83e81a4
ToppCell	5'-Adult-LargeIntestine-Hematopoietic-Plasma_cells\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	IGHV3-53 IGHV3-49 IGHV3-33 IGHV3-30 IGHV3-23 IGHV3-21 IGHV3-20 IGHV3-66	2.01e-07	190	144	8	79ee6d10dfbb775da149a1104da5823cf63bbb46
ToppCell	5'-Adult-LargeIntestine-Hematopoietic-Plasma_cells-IgA_plasma_cell\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	IGHV3-53 IGHV3-49 IGHV3-33 IGHV3-30 IGHV3-23 IGHV3-21 IGHV3-20 IGHV3-66	2.01e-07	190	144	8	18762ce78ed0b206ade19e1c8ff76a2647489f68
ToppCell	Tracheal-10x5prime-Immune_Lymphocytic-B-B_plasma\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	IGHV3-53 IGHV3-49 IGHV3-33 IGHV3-30 IGHV3-23 IGHV3-21 IGHV3-20 IGHV3-66	2.27e-07	193	144	8	282b47dae6043eabb1e13d41d91c07b5ec21cd65
ToppCell	renal_papilla_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	KIF13B NEK10 PIEZO1 LEMD1 PTPN13 PTPRJ CDH1 VWA5B1	2.36e-07	194	144	8	04bfc555743f7d8821439d05ae442d15e9886c59
ToppCell	renal_papilla_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	KIF13B NEK10 PIEZO1 LEMD1 PTPN13 PTPRJ CDH1 VWA5B1	2.36e-07	194	144	8	69bff17df4a760ccf081cf52ff04af02c14f448d
ToppCell	Parenchymal-10x5prime-Immune_Lymphocytic-B-B_plasma-B_plasma_IgG\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	IGHV3-53 IGHV3-49 IGHV3-38 IGHV3-33 IGHV3-30 IGHV3-23 IGHV3-21 IGHV3-66	2.45e-07	195	144	8	f3f7f1a77a1edd2b50a8211c76fe289738eb04cf
ToppCell	Biopsy_IPF-Immune-Plasma_cells\|Biopsy_IPF / Sample group, Lineage and Cell type	IGHV3-53 IGHV3-49 IGHV3-33 IGHV3-30 IGHV3-23 IGHV3-21 IGHV3-20 IGHV3-66	2.55e-07	196	144	8	a1b6a8000b86efcb07843998aa3a49bb1f54bcda
ToppCell	Tracheal-10x5prime-Immune_Lymphocytic-B\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	IGHV3-53 IGHV3-49 IGHV3-33 IGHV3-30 IGHV3-23 IGHV3-21 IGHV3-20 IGHV3-66	2.65e-07	197	144	8	2662138671262b30508c5759038bcdcfe6551696
ToppCell	5'-Adult-Appendix-Mesenchymal-fibroblastic-Stromal_1_(CCL11+)\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	CHL1 ABCA1 OBSCN PCDHA4 FNDC1 PTPN13 CRYBG3	1.61e-06	174	144	7	f90ca117b729436cf452e2ddcec26ba525c5c13b
ToppCell	3'_v3-bone_marrow-Lymphocytic_B_plasma-Plasma_cells\|bone_marrow / Manually curated celltypes from each tissue	IGHV3-53 IGHV3-33 IGHV3-30 IGHV3-23 IGHV3-21 CLPTM1L IGHV3-66	1.68e-06	175	144	7	51301f3f44d3e88397f367cedd1e2abaa2be4c6f
ToppCell	metastatic_Brain-B_lymphocytes-MALT_B_cells\|metastatic_Brain / Location, Cell class and cell subclass	IGHV3-53 IGHV3-30 IGHV3-23 IGHV3-21 IGHV3-20 STARD5 IGHV3-66	1.74e-06	176	144	7	50e207403d48ce1b55a78897adb5519a2430a626
ToppCell	PBMC-Control-Lymphocyte-B-Plasmablast-Plasmablast-\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)	IGHV3-53 IGHV3-49 IGHV3-38 IGHV3-33 IGHV3-30 IGHV3-23 IGHV3-21	1.81e-06	177	144	7	4c434a7b7cc54cf4dac996bbc3f5124d9ef9a9cd
ToppCell	PBMC-Control-Lymphocyte-B-Plasmablast-Plasmablast\|Control / Location, Disease Group, Cell group, Cell class (2021.03.09)	IGHV3-53 IGHV3-49 IGHV3-38 IGHV3-33 IGHV3-30 IGHV3-23 IGHV3-21	1.81e-06	177	144	7	d746122bf8d208c3aa4d156e8c12d0a0e555c6e5
ToppCell	PBMC-Control-Lymphocyte-B-Plasmablast\|Control / Location, Disease Group, Cell group, Cell class (2021.03.09)	IGHV3-53 IGHV3-49 IGHV3-38 IGHV3-33 IGHV3-30 IGHV3-23 IGHV3-21	1.81e-06	177	144	7	fc40918825b7e1eb6861df59dfca944778a64b98
ToppCell	PBMC-Control-Lymphocyte-B-Plasmablast\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	IGHV3-53 IGHV3-49 IGHV3-38 IGHV3-33 IGHV3-30 IGHV3-23 IGHV3-21	1.95e-06	179	144	7	837ed81f18257f444eaeadc4fac89deedd4e3061
ToppCell	PBMC-Control-Lymphocyte-B-Plasmablast-Plasmablast-Plasmablast\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	IGHV3-53 IGHV3-38 IGHV3-33 IGHV3-30 IGHV3-23 IGHV3-21 IGHV3-20	1.95e-06	179	144	7	494febe77c6d4e6a2c6f0928bbf4c84b0301f188
ToppCell	PBMC-Control-Lymphocyte-B-Plasmablast-Plasmablast\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	IGHV3-53 IGHV3-49 IGHV3-38 IGHV3-33 IGHV3-30 IGHV3-23 IGHV3-21	1.95e-06	179	144	7	b6ee4f41d8fb5f047b7bdd8489dda0a89fc6d43f
ToppCell	droplet-Limb_Muscle-Pre-Sort-18m-Macroglial-nan\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CHL1 MAG MPZ DIS3L2 COQ5 PRX SEPTIN3	2.18e-06	182	144	7	c00e503f442d44fbae73c5e2dc85be69e294e67a
ToppCell	BAL-Mild-Lymphocyte-B-B_cell-B_cell\|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)	IGHV3-53 IGHV3-33 IGHV3-30 IGHV3-23 IGHV3-21 NCR3 IGHV3-66	2.34e-06	184	144	7	3f8a359e40bebe58545f708682e5e5d1b70cf5cb
ToppCell	BAL-Mild-Lymphocyte-B-B_cell-B_cell-\|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)	IGHV3-53 IGHV3-33 IGHV3-30 IGHV3-23 IGHV3-21 NCR3 IGHV3-66	2.34e-06	184	144	7	64bede8db709fd32f40c03265b96f0b12155bb8a
ToppCell	3'-Broncho-tracheal-Immune_Lymphocytic-Lymphocytic_B-plasma_cell-Plasma_cells\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	IGHV3-53 IGHV3-49 IGHV3-30 IGHV3-23 IGHV3-21 IGHV3-20 IGHV3-66	2.34e-06	184	144	7	15f2c10101ccc8ed059520fc082ee42593dff269
ToppCell	3'-Broncho-tracheal-Immune_Lymphocytic-Lymphocytic_B-plasma_cell\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	IGHV3-53 IGHV3-49 IGHV3-30 IGHV3-23 IGHV3-21 IGHV3-20 IGHV3-66	2.34e-06	184	144	7	a90a58d9e319afa1cd572e4c2f516fadc42f56e5
ToppCell	BAL-Mild-Lymphocyte-B-B_cell\|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09)	IGHV3-53 IGHV3-33 IGHV3-30 IGHV3-23 IGHV3-21 NCR3 IGHV3-66	2.42e-06	185	144	7	609080adb2cfb105bb7b8efb617553833299f371
ToppCell	5'-Parenchyma_lung-Immune_Lymphocytic-Lymphocytic_B-plasma_cell-Plasma_cells\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	IGHV3-53 IGHV3-33 IGHV3-30 IGHV3-23 IGHV3-21 IGHV3-20 IGHV3-66	2.42e-06	185	144	7	08bc817908076734d66f2805cb954141f2cc5a18
ToppCell	5'-Parenchyma_lung-Immune_Lymphocytic-Lymphocytic_B-plasma_cell\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	IGHV3-53 IGHV3-33 IGHV3-30 IGHV3-23 IGHV3-21 IGHV3-20 IGHV3-66	2.42e-06	185	144	7	1704a12153a9b107bf03ecccd1a036cf61334d7a
ToppCell	Mild_COVID-19-B_cell-B_cell\|Mild_COVID-19 / Disease group,lineage and cell class （2021.01.30）	IGHV3-53 IGHV3-33 IGHV3-30 IGHV3-23 IGHV3-21 NCR3 IGHV3-66	2.51e-06	186	144	7	855a5a00ba2aa1b5c63b8db56d026ddecc546050
ToppCell	RV-04._Ventricular_Cardiomyocyte_I\|World / Chamber and Cluster_Paper	ACACB NEBL NEK10 ACO2 OBSCN MICAL3 ALPK2	2.60e-06	187	144	7	78cdcf8bc141d3b155c3c8af908431fc419c4d08
ToppCell	3'_v3-lymph-node_spleen-Lymphocytic_B_plasma-Plasma_cells\|lymph-node_spleen / Manually curated celltypes from each tissue	IGHV3-33 IGHV3-30 IGHV3-23 IGHV3-21 DDOST STARD5 CLPTM1L	2.70e-06	188	144	7	c7b1807c96f87fbcd37739a159cf00f9a1ff5d71
ToppCell	healthy_donor-Lymphocytic-Plasma_cell\|healthy_donor / Disease condition, Lineage, Cell class and subclass	IGHV3-53 IGHV3-38 IGHV3-33 IGHV3-23 IGHV3-21 CLPTM1L IGHV3-66	2.70e-06	188	144	7	bd53b0371154cff680226897b61c9809a239d1b6
ToppCell	5'-Parenchyma_lung-Immune_Lymphocytic-Lymphocytic_B-plasma_cell-Plasma_cells-Plasma_cells_L.1.7.1.0\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	IGHV3-53 IGHV3-33 IGHV3-30 IGHV3-23 IGHV3-21 CHAC2 IGHV3-66	2.70e-06	188	144	7	6844cebca177fdf38b21a40d606230a033717a3a
ToppCell	3'_v3-bone_marrow-Lymphocytic_B_plasma\|bone_marrow / Manually curated celltypes from each tissue	IGHV3-53 IGHV3-33 IGHV3-30 IGHV3-23 IGHV3-21 CHAC2 CLPTM1L	2.79e-06	189	144	7	dceb011216deb4ffd830144a53c635c05dff5ec5
ToppCell	droplet-Limb_Muscle-nan-18m-Macroglial-nan\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CHL1 MAG MPZ DPYSL5 PRX CDH1 ALPK2	2.89e-06	190	144	7	e2481bd5166fde2cdc0c3824894f2bccb8294fdd
ToppCell	renal_papilla_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Inner_Medullary_Collecting_Duct_Cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	KIF13B NEK10 LEMD1 PTPN13 PTPRJ CDH1 VWA5B1	2.99e-06	191	144	7	3e828cffa24ded19f591a7ed6c1fe88ad57fdcac
ToppCell	Parenchymal-NucSeq-Immune_Lymphocytic-B-B_plasma-B_plasma_IgA\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	IGHV3-53 IGHV3-33 IGHV3-30 IGHV3-23 IGHV3-21 IGHV3-20 STARD5	3.21e-06	193	144	7	5c5543e7c83ecea44d23521246592c0301044173
ToppCell	COVID_non-vent-Lymphocytic-Plasma_cell-IgM_Plasmablast\|COVID_non-vent / Disease condition, Lineage, Cell class and subclass	IGHV3-53 IGHV3-38 IGHV3-23 IGHV3-21 IGHV3-20 IGHV3-9 CLPTM1L	3.21e-06	193	144	7	7b4b0271e4fbece703876acb053ae236afb7cdba
ToppCell	Tracheal-10x5prime-Immune_Lymphocytic-B-B_plasma-B_plasma_IgG\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	IGHV3-53 IGHV3-49 IGHV3-30 IGHV3-23 IGHV3-21 IGHV3-20 IGHV3-66	3.32e-06	194	144	7	a4a70369541876e1192df8828b63e3d1746ae3d9
ToppCell	Parenchymal-10x3prime_v2-Immune_Lymphocytic-B-B_plasma-B_plasma_IgG\|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations	IGHV3-53 IGHV3-38 IGHV3-23 IGHV3-21 IGHV3-20 STARD5 IGHV3-66	3.43e-06	195	144	7	2d18f08f33f3b261c77b8adf87d1a184cc6d7400
ToppCell	Bronchial-10x5prime-Immune_Lymphocytic-B-B_plasma-B_plasma_IgA\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	IGHV3-53 IGHV3-33 IGHV3-30 IGHV3-23 IGHV3-21 IGHV3-20 IGHV3-66	3.43e-06	195	144	7	13f4ee21568fd747608412d33559d10561dbb3c8
ToppCell	Biopsy_Other_PF-Immune-Plasma_cells\|Biopsy_Other_PF / Sample group, Lineage and Cell type	IGHV3-53 IGHV3-33 IGHV3-30 IGHV3-23 IGHV3-21 IGHV3-20 IGHV3-66	3.43e-06	195	144	7	d0305c6a68c9e361507b04db94f86873085d49b3
ToppCell	Tracheal-10x5prime-Immune_Lymphocytic-B-B_plasma-B_plasma_IgA\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	IGHV3-53 IGHV3-49 IGHV3-33 IGHV3-30 IGHV3-23 IGHV3-21 IGHV3-20	3.43e-06	195	144	7	df009b18898c10686f75cf72b4ec0eff18f5bb50
ToppCell	mLN-B_cell-B_cell_IgG_Plasma\|mLN / Region, Cell class and subclass	IGHV3-53 IGHV3-33 IGHV3-30 LAMA3 PHYHD1 CDH1 IGHV3-66	3.55e-06	196	144	7	03b79f237e4f7ebab46b277d05377569c6342cf7
ToppCell	mLN-(2)_B_cell-(21)_B_cell_IgG_Plasma\|mLN / shred on region, Cell_type, and subtype	IGHV3-53 IGHV3-33 IGHV3-30 LAMA3 PHYHD1 CDH1 IGHV3-66	3.55e-06	196	144	7	e8b12b046d42a58e6f4d9419ab05a5c55e764f34
ToppCell	Bronchial-10x5prime-Immune_Lymphocytic-B-B_plasma-B_plasma_IgG\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	IGHV3-38 IGHV3-33 IGHV3-30 IGHV3-23 IGHV3-21 IGHV3-20 IGHV3-66	3.55e-06	196	144	7	fec21383435779bf4c632decd3d29c6ca7baebfb
ToppCell	Biopsy_Control_(H.)-Immune-Plasma_cells\|Biopsy_Control_(H.) / Sample group, Lineage and Cell type	IGHV3-53 IGHV3-33 IGHV3-30 IGHV3-23 IGHV3-21 IGHV3-20 IGHV3-66	3.67e-06	197	144	7	275f38ed7e477000e864cecf9b7d49ae134c3b6a
ToppCell	COVID_non-vent-Lymphocytic-Plasma_cell-IgG_Plasmablast\|COVID_non-vent / Disease condition, Lineage, Cell class and subclass	IGHV3-53 IGHV3-33 IGHV3-30 IGHV3-23 IGHV3-21 CLPTM1L IGHV3-66	3.67e-06	197	144	7	b754fad4f3caae6de95df901fd96ea8697fe41b1
ToppCell	COVID_non-vent-Lymphocytic-Plasma_cell-IgA_Plasmablast\|COVID_non-vent / Disease condition, Lineage, Cell class and subclass	IGHV3-33 IGHV3-30 IGHV3-23 IGHV3-21 CHAC2 DDOST CLPTM1L	3.67e-06	197	144	7	fdbf4eb9fa5aefb4ffb307494fe4774bf5e0aaeb
ToppCell	Parenchymal-10x5prime-Immune_Lymphocytic-B\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	IGHV3-53 IGHV3-33 IGHV3-30 IGHV3-23 IGHV3-21 IGHV3-20 IGHV3-66	3.67e-06	197	144	7	9fe1b757f76c2d43d39aa9ac500eaba98723985c
ToppCell	supra_basal_cell\|World / shred by cell class for nasal brushing	PSMA3 PHYHD1 DDOST SLC3A2 ADH5 CCT5 FKBP3	4.06e-06	200	144	7	542bdcec563644e01887fd85eb158b32db439b03
ToppCell	Cerebellum-Neuronal-Excitatory-eN2(Slc17a7_Slc17a6)-Slc17a6-Excitatory_Neuron.Slc17a6.Sln_(Unipolar_brush_cell)-\|Cerebellum / BrainAtlas - Mouse McCarroll V32	RBP3 OBSCN ACTN3 CCDC88B TARBP1	1.23e-05	92	144	5	a5b89f971b904b8e280fe66996a7f8efd92c2132
ToppCell	Cerebellum-Neuronal-Excitatory-eN2(Slc17a7_Slc17a6)-Slc17a6-Excitatory_Neuron.Slc17a6.Sln_(Unipolar_brush_cell)\|Cerebellum / BrainAtlas - Mouse McCarroll V32	RBP3 OBSCN ACTN3 CCDC88B TARBP1	1.23e-05	92	144	5	b867cd7923585b13beaf086c40781bab2d7b7434
ToppCell	wk_08-11-Mesenchymal-Myofibro_&_SMC-Late_airway_SMC\|wk_08-11 / Celltypes from embryonic and fetal-stage human lung	PITPNM2 NR4A2 TECTA FNDC1 NALCN KLHL4	1.52e-05	163	144	6	1e8730d75cccf7292010683ab4e81a69d8e3bfa9
ToppCell	droplet-Heart-HEART_(ALL_MINUS_AORTA)-30m-Hematologic-fibroblast\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MAG KIF13B SYT3 CCDC88B PRX FNDC1	1.74e-05	167	144	6	f5bffa77061baec0ba87bd688a047595f32534db
ToppCell	E18.5-Endothelial-Endothelial_blood-vessel-Microvascular_EC-CAP2-CAP2_mature\|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	PCDHA2 PRX AFAP1L1 IGFBP7 CRYBG3 SLC29A4	1.87e-05	169	144	6	41ad349806b279fbe1374b7e3cc7f146a11adb44
ToppCell	PND07-Endothelial-Endothelial_blood-vessel-Microvascular_EC-CAP2-CAP2_prolif\|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	PITPNM2 PRX AFAP1L1 IGFBP7 CRYBG3 FKBP1A	1.87e-05	169	144	6	8a6d05b5d60b2b2e43a8ff7521feb79cd6dbd940
ToppCell	E18.5-Endothelial-Endothelial_blood-vessel-Microvascular_EC-CAP2\|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	PCDHA2 PRX AFAP1L1 IGFBP7 CRYBG3 SLC29A4	1.87e-05	169	144	6	42782c61592742190ab0cba8a94f8bdf9c278f90
ToppCell	3'-GW_trimst-1.5-LargeIntestine-Neuronal-neurons_B-Branch_B1_(eMN)\|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	KIF13B ADGRB1 DPYSL5 LEMD1 SEPTIN3 ZFHX2	2.20e-05	174	144	6	271c51d220842402975d97c86c9acfdbdf62a32c
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Immune-Myeloid-Macrophage_Dendritic-Cycling_Mononuclear_Phagocyte\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	DTL ADGRB1 STARD5 SEPTIN3 CANT1 IQGAP3	2.27e-05	175	144	6	f7d191cde68de8f3457fa62b1df53b6d0dbe5001
ToppCell	COPD-Lymphoid-B_Plasma\|World / Disease state, Lineage and Cell class	IGHV3-53 IGHV3-33 IGHV3-30 IGHV3-23 IGHV3-21 IGHV3-20	2.27e-05	175	144	6	d73ee324479172501481b54967a0f3bd870fcf3a
ToppCell	PBMC-Control-Lymphocyte-B-B_cell-B_naive-B_naive-1\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	CHL1 IGHV3-33 IGHV3-30 IGHV3-23 IGHV3-21 IGHV3-9	2.35e-05	176	144	6	ad05dd934f4ac2e656b3455de091f4c8772de6c8
ToppCell	Control-Lymphoid_P-Plasmablast\|Control / Disease group, lineage and cell class	IGHV3-38 IGHV3-33 IGHV3-30 IGHV3-23 IGHV3-21 IGHV3-9	2.35e-05	176	144	6	4b4416f342b732d2cc60133838728880326257d8
ToppCell	Control-Lymphoid_P\|Control / Disease group, lineage and cell class	IGHV3-38 IGHV3-33 IGHV3-30 IGHV3-23 IGHV3-21 IGHV3-9	2.35e-05	176	144	6	d895a6b295cd649273ff80ad7785a3e0ae4c728a
ToppCell	(2)_Plasma_cells\|World / Lung cell shreds - cell class (v4) and cell subclass (v4)	IGHV3-33 IGHV3-30 IGHV3-23 IGHV3-21 IGHV3-20 IGHV3-66	2.42e-05	177	144	6	ed3c936bb69f9bc7291b4f6cde1d204078117c48
ToppCell	VE-plasma\|VE / Condition, Cell_class and T cell subcluster	IGHV3-53 IGHV3-49 IGHV3-30 IGHV3-23 IGHV3-21 IGHV3-20	2.42e-05	177	144	6	0c1cc0834de55717cb4f69d020339060ce2c9a03
ToppCell	-IPF_03\|World / lung cells shred on cell class, cell subclass, sample id	IGHV3-53 IGHV3-49 IGHV3-23 IGHV3-21 IGHV3-20 STARD5	2.42e-05	177	144	6	ae2d2e138946535596fa30a55207f261cafda461
ToppCell	VE-plasma-\|VE / Condition, Cell_class and T cell subcluster	IGHV3-53 IGHV3-49 IGHV3-30 IGHV3-23 IGHV3-21 IGHV3-20	2.42e-05	177	144	6	3a3c94cf30012e2aa266bc4d7fe772e45fa90f6d
ToppCell	droplet-Fat-SCAT-30m-Mesenchymal-nan\|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MAG MPZ CCDC8 PRX FNDC1 ALPK3	2.50e-05	178	144	6	5cf12927f0756c4d8a289fe4308d736382e6212e
ToppCell	5'-Parenchyma_lung-Immune_Lymphocytic-Lymphocytic_B\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	IGHV3-53 IGHV3-33 IGHV3-30 IGHV3-23 IGHV3-21 IGHV3-66	2.50e-05	178	144	6	107dae8b00c4257697a63700e72bb434cdb8406f
ToppCell	3'-Broncho-tracheal-Immune_Lymphocytic-Lymphocytic_B-plasma_cell-Plasma_cells-Plasma_cells_L.1.7.0.1\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	IGHV3-53 IGHV3-30 IGHV3-23 IGHV3-21 IGHV3-20 IGHV3-66	2.66e-05	180	144	6	cea079bc02e08c46600eed05ab9924ec90e1e3d3
ToppCell	5'-Parenchyma_lung-Immune_Lymphocytic-Lymphocytic_B-plasma_cell-Plasma_cells-Plasma_cells_L.1.7.1.1\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	IGHV3-53 IGHV3-33 IGHV3-30 IGHV3-23 IGHV3-21 IGHV3-66	2.66e-05	180	144	6	e3877f6ef5f54ff689058b4c996ab1851822f871
ToppCell	BAL-Severe-Lymphocyte-B-Plasmablast-Plasmablast-Plasmablast\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	IGHV3-53 IGHV3-49 IGHV3-30 IGHV3-23 IGHV3-20 IGHV3-66	2.66e-05	180	144	6	6a777a308fa3160d31eda468db930e71862020b2
ToppCell	3'-GW_trimst-2-SmallIntestine-Neuronal-Glial_immature-Glia_1_(DHH+)\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	CHL1 MAG MPZ NAT16 NR4A2 TMEM132B	2.66e-05	180	144	6	38490017dd590e3fcfa7e88d8d15235d55f90cf1
ToppCell	10x5'-Lung-Lymphocytic_B\|Lung / Manually curated celltypes from each tissue	CHL1 IGHV3-33 IGHV3-30 IGHV3-21 MICAL3 IGHV3-66	2.83e-05	182	144	6	310f94437d197eaaaf6e30e68063b33e94befe77
ToppCell	cellseq-Immune-Lymphocytic_B-Lymphocytic_B-Plasma\|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	IGHV3-53 IGHV3-33 IGHV3-30 IGHV3-23 IGHV3-21 IGHV3-66	2.92e-05	183	144	6	5ab4aa0304b832f98fff89b6c24ad5b7dd014c11
ToppCell	droplet-Limb_Muscle-Pre-Sort-18m-Macroglial-unknown\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CHL1 MAG MPZ PRX SEPTIN3 CDH1	3.10e-05	185	144	6	11c147f3f5570c4761d2bcff3bad28146b4a5861
ToppCell	facs-Trachea-18m-Endothelial-endothelial_cell_of_trachea-tracheal_endothelial_cell-tracheal_endothelial_cell_l54\|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	TRIM72 ABCA1 ACACB BCR AFAP1L1 KLHL4	3.10e-05	185	144	6	59acaf025353405948dc34ccccf37ec5c08ea903
ToppCell	droplet-Limb_Muscle-MUSCLE-30m-Macroglial-nan\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CHL1 MAG MPZ ADGRB1 PRX CDH1	3.30e-05	187	144	6	16e55d802fc4e71878305e61ad03806aabd59537
ToppCell	cellseq2-Immune-Lymphocytic_B-Lymphocytic_B-Plasma\|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	IGHV3-33 IGHV3-30 IGHV3-23 IGHV3-21 STARD5 CLPTM1L	3.40e-05	188	144	6	33360f1c30315d9772731c9067834dc059172b79
ToppCell	PBMC-Mild-Lymphocyte-B-Plasmablast-Plasmablast\|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)	IGHV3-30 IGHV3-23 IGHV3-21 IGHV3-20 CHAC2 CLPTM1L	3.50e-05	189	144	6	31594cc59eb1c5b01407dfd72b1487ecca8bf5ec
ToppCell	facs-Lung-nan-3m-Endothelial-Capillary_Aerocyte_endothelial_cell\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PITPNM2 DPYSL5 PRX AFAP1L1 FNDC1 IGFBP7	3.50e-05	189	144	6	09dd2b3d89416192e84abe302a6237b8f3fdcb6e
ToppCell	RV-04._Ventricular_Cardiomyocyte_I\|RV / Chamber and Cluster_Paper	NEBL NEK10 ACO2 OBSCN MICAL3 ALPK2	3.50e-05	189	144	6	9c1debd65c13d63fd4f3158917d621b44b714c26
ToppCell	RV-06._Ventricular_Cardiomyocyte_II\|World / Chamber and Cluster_Paper	ACACB NEBL NEK10 OBSCN MICAL3 ALPK2	3.50e-05	189	144	6	5e80c47f63980904c4c1ff02c201b67b456a0974
ToppCell	PBMC-Mild-Lymphocyte-B-Plasmablast-Plasmablast-\|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)	IGHV3-30 IGHV3-23 IGHV3-21 IGHV3-20 CHAC2 CLPTM1L	3.50e-05	189	144	6	c296660061b46e3abae1e7cf29df20274e5a8add
ToppCell	COVID-19-lung-Plasmablasts\|COVID-19 / Disease (COVID-19 only), tissue and cell type	IGHV3-33 IGHV3-30 IGHV3-23 IGHV3-21 DTL CLPTM1L	3.50e-05	189	144	6	fdf6c945b352614885e646a5ef4bc576dee73895
ToppCell	LPS_only-Endothelial-Endothelial-Alv_Gen_Intermediate\|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	PITPNM2 ACACB DTL PRX AFAP1L1 KLHL4	3.50e-05	189	144	6	e82211b9dc7540e7a183be2cbcfae39fdf503949
ToppCell	PBMC-Mild-Lymphocyte-B-Plasmablast\|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09)	IGHV3-30 IGHV3-23 IGHV3-21 IGHV3-20 CHAC2 CLPTM1L	3.50e-05	189	144	6	9de17ade3cc3e9cd1394338bd048fb1ce64ac50f
ToppCell	facs-Lung-3m-Endothelial-capillary_endothelial-capillary_endothelial_cell-capillary_aerocyte_endothelial_cell\|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	PITPNM2 DPYSL5 PCDHA2 PRX AFAP1L1 IGFBP7	3.60e-05	190	144	6	52213cd2a6a20772d4f49ba9ac0407abafa528db
ToppCell	RV-06._Ventricular_Cardiomyocyte_II\|RV / Chamber and Cluster_Paper	ACACB NEBL NEK10 OBSCN MICAL3 ALPK2	3.60e-05	190	144	6	fe8e78922c8ae928ef9a80bffd67868d5a87a091
ToppCell	LV-04._Ventricular_Cardiomyocyte_I\|LV / Chamber and Cluster_Paper	ACACB NEBL ACO2 OBSCN MICAL3 ALPK2	3.82e-05	192	144	6	ad19e2c1d36a0566c9b12ced10db78f4781c8ea6
ToppCell	BAL-Control-Lymphocyte-B-B_cell-B_cell-\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)	IGHV3-49 IGHV3-33 IGHV3-30 IGHV3-23 IGHV3-21 NCR3	3.93e-05	193	144	6	bcda1fb3db7d4c276e3370250a2b79fedd807fc5
ToppCell	PND01-Endothelial-Endothelial_blood-vessel-Microvascular_EC-CAP2-CAP2_mature\|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	DPYSL5 PCDHA2 PRX AFAP1L1 IGFBP7 FKBP1A	3.93e-05	193	144	6	b6b065b0c2ad31d1488dfa970450b29a8ac1f3aa
ToppCell	BAL-Control-Lymphocyte-B-B_cell-B_cell\|Control / Location, Disease Group, Cell group, Cell class (2021.03.09)	IGHV3-49 IGHV3-33 IGHV3-30 IGHV3-23 IGHV3-21 NCR3	3.93e-05	193	144	6	befab58da635723db4f9270d087afa981fc45bf1
Disease	lung squamous cell carcinoma (is_implicated_in)	CHRNA5 CLPTM1L PTPN13 PTPRJ	4.66e-06	24	139	4	DOID:3907 (is_implicated_in)
Disease	lung large cell carcinoma (is_marker_for)	CHRNA5 PTPN13	2.20e-05	2	139	2	DOID:4556 (is_marker_for)
Disease	achromatopsia (implicated_via_orthology)	PDE6C GNAT2	2.20e-05	2	139	2	DOID:13911 (implicated_via_orthology)
Disease	primary microcephaly (implicated_via_orthology)	RRP7BP RRP7A	6.59e-05	3	139	2	DOID:0070297 (implicated_via_orthology)
Disease	lung adenocarcinoma (is_implicated_in)	CHRNA5 CLPTM1L PTPN13 PTPRJ	8.48e-05	49	139	4	DOID:3910 (is_implicated_in)
Disease	HYPERTROPHIC NEUROPATHY OF DEJERINE-SOTTAS	MPZ PRX	1.31e-04	4	139	2	145900
Disease	Dejerine-Sottas disease	MPZ PRX	1.31e-04	4	139	2	cv:C0011195
Disease	Charcot-Marie-Tooth disease type 3 (is_implicated_in)	MPZ PRX	1.31e-04	4	139	2	DOID:0050540 (is_implicated_in)
Disease	Progressive cone dystrophy (without rod involvement)	PDE6C GNAT2	1.31e-04	4	139	2	C0271092
Disease	Achromatopsia	PDE6C GNAT2	2.18e-04	5	139	2	cv:C0152200
Disease	Hereditary, Type VII, Motor and Sensory Neuropathy	MPZ PRX	3.26e-04	6	139	2	C0019816
Disease	Hereditary Motor and Sensory Neuropathies	MPZ PRX	3.26e-04	6	139	2	C0027888
Disease	Achromatopsia	PDE6C GNAT2	4.56e-04	7	139	2	C0152200
Disease	Dejerine-Sottas Disease (disorder)	MPZ PRX	4.56e-04	7	139	2	C0011195
Disease	lung squamous cell carcinoma (is_marker_for)	CHRNA5 CLPTM1L PTPN13	6.52e-04	36	139	3	DOID:3907 (is_marker_for)
Disease	lung adenocarcinoma (is_marker_for)	CHRNA5 SLC3A2 CLPTM1L PTPN13	7.11e-04	85	139	4	DOID:3910 (is_marker_for)
Disease	Uveitis	RBP3 CRYBB2	7.76e-04	9	139	2	C0042164
Disease	cholate measurement	CCDC8 PNMA8C	9.67e-04	10	139	2	EFO_0021509
Disease	Kidney Failure, Chronic	ABCA1 ACAT1 CRP	1.52e-03	48	139	3	C0022661
Disease	Charcot-Marie-Tooth disease type 4	MPZ PRX	1.66e-03	13	139	2	cv:C4082197
Disease	psychosis	MPZ NALCN	1.93e-03	14	139	2	EFO_0005407
Disease	Left ventricular noncompaction	MIB2 MIB1	1.93e-03	14	139	2	C1960469
Disease	Metastatic melanoma	NEK10 ALPK3 ALPK2	2.13e-03	54	139	3	C0278883
Disease	nasopharynx carcinoma (is_implicated_in)	CHRNA5 CLPTM1L	2.22e-03	15	139	2	DOID:9261 (is_implicated_in)
Disease	central nervous system disease (implicated_via_orthology)	ACO2 GEMIN5	2.53e-03	16	139	2	DOID:331 (implicated_via_orthology)
Disease	diabetic neuropathy (biomarker_via_orthology)	MPZ NTRK1	2.86e-03	17	139	2	DOID:9743 (biomarker_via_orthology)
Disease	oral squamous cell carcinoma (is_marker_for)	NAIP PTPN13 CDH1	3.30e-03	63	139	3	DOID:0050866 (is_marker_for)
Disease	familial hyperlipidemia (biomarker_via_orthology)	ABCA1 CRP	3.57e-03	19	139	2	DOID:1168 (biomarker_via_orthology)
Disease	Hereditary Non-Polyposis Colon Cancer Type 2	PTPRJ CDH1	3.57e-03	19	139	2	C1333991
Disease	Colorectal cancer, hereditary nonpolyposis, type 1	PTPRJ CDH1	3.57e-03	19	139	2	C2936783
Disease	Malaria	CRP NCR3	3.96e-03	20	139	2	C0024530

Protein segments in the cluster

Peptide	Gene	Start	Entry
KDWPRESAVGVAALA	NAIP	286	Q13075
KVAEKEGWPLDIRVG	ACO2	366	Q99798
VEKAGSVLVQAGPWV	CRYBB2	46	P43320
KSEGALEVQVWEGPI	CCDC88B	701	A6NC98
VIGGRDTPGAKVALW	CRYBG3	2896	Q68DQ2
FGAVIWKETPAGEVA	ADGRB1	586	O14514
EATIVGVRKTGQIWP	BCR	401	P11274
ASDGGLIIPDKVWAV	ALPK2	1261	Q86TB3
AVAWEAGKPLSIEEI	ADH5	11	P11766
GLLVPKVDERKTAWG	ADCY6	6	O43306
GVVDPGKVSKAAWIR	FBXW10	1011	Q5XX13
VPEKEVGKVGEWAIR	ABCA1	2016	O95477
WAKDQRPVGEVGRSA	ALPK3	1511	Q96L96
EGGVKVLITGPWTEA	CAMTA2	546	O94983
ARPTVIRWSEGGKEV	PRKAB2	76	O43741
LGKQEVIRGWEEGVA	FKBP1A	51	P62942
WVPGELKLVTAAGDQ	DTL	106	Q9NZJ0
TPEGKILDEWFGRTI	DIS3L2	471	Q8IYB7
AGPDEVRAWTIRKGT	OLA1	311	Q9NTK5
VPWSVGAGHVVAKVR	PCDHA2	581	Q9Y5H9
SWREEGFPVGLKLAV	LEMD1	146	Q68G75
VDIAKRIPVQAVWAG	ACACB	336	O00763
RWEEEGLGGVPEQKL	NTRK1	161	P04629
GNETWGDPRVIKVIT	PTPRJ	191	Q12913
VRQAPGKGLEWVSVI	IGHV3-66	56	A0A0C4DH42
SDLGGVPWKEAVRIH	MICAL3	956	Q7RTP6
GKRWPIVGVRLVSEF	GPD2	516	P43304
VRQAPGKGLEWVAVI	IGHV3-30-5	56	P0DP03
WAKIGPVGAVVAFAI	MAG	511	P20916
ITPGIWVACIKAEGV	LAMA3	841	Q16787
GSVTWFRDEVVPGKE	NCR3	51	O14931
GNKEEPGRWEELTRV	CHL1	651	O00533
VRQAPGKGLEWVAVI	IGHV3-30-3	56	P0DP02
IRQAPGKGLEWVSSI	IGHV3-38	56	A0A0C4DH36
VRQAPGKGLEWVSGI	IGHV3-9	56	P01782
VRQAPGKGLEWVSSI	IGHV3-38-3	56	P0DTE1
AVGSDADIVIWDPKG	DPYS	396	Q14117
IEVWPVLAVIGGVDA	HERC1	2301	Q15751
LVVEKDAVFIPAGWD	DYNC1LI2	301	O43237
VPWVILSDGDGTVEK	CANT1	196	Q8WVQ1
GPDDGSVVVWSIAKR	CFAP52	131	Q8N1V2
EGREGFVVKVRGLPW	HNRNPH2	6	P55795
DPETSVEIRIWGGIK	NEK10	321	Q6ZWH5
DKEVVFPLDIGIVGW	PDE6C	131	P51160
RIWDVKAAGVRIVIP	PEX7	181	O00628
GETVLVEGLRVAPWE	NAT16	116	Q8N8M0
VEGLRVAPWERGKGV	NAT16	121	Q8N8M0
KPGGIIVRWCKVDDD	CRLF3	191	Q8IUI8
KTAVWEEGPGGELVI	ERAL1	371	O75616
LGAKAVFVGRPIVWG	HAO1	306	Q9UJM8
WGSVELPIVGKAFIR	PEDS1	101	A5PLL7
LEDIVKRDGFPLWVG	LY75	1441	O60449
GIIKWGDPVTRVLDD	NSF	506	P46459
VRQAPGKGLEWVSGI	IGHV3-20	56	A0A0C4DH32
RGGPEKHEVTGWVLV	IGFBP7	221	Q16270
DPKVRAGAVDVVRHW	PITPNM2	1126	Q9BZ72
VRQAPGKGLEWVGFI	IGHV3-49	56	A0A0A0MS15
SRWVFKEEGVLRVGP	DDOST	296	P39656
VRQAPGKGLEWVSSI	IGHV3-21	56	A0A0B4J1V1
EWKEEVPVNIGRAGA	KLHL4	696	Q9C0H6
KAQVTGDPGAVLWLE	IQGAP3	576	Q86VI3
VEGVGARVVRGPDWK	MIB1	11	Q86YT6
GEVYADGVLLVWKPV	OBSCN	7566	Q5VST9
VPWSVGVGHVVAKVR	PCDHA4	581	Q9UN74
EWERVRGGVPLVKEK	EIF3CL	301	B5ME19
GGIKVIRVPSDSVWT	CHRNA5	116	P30532
EEDPGVLVGVVKAWD	CDHR2	706	Q9BYE9
WVTALNEEAERKGGP	C2CD2	81	Q9Y426
PQGTKWVVDLDRGLV	FNDC1	1351	Q4ZHG4
VIDSIVGDGIEPSKW	FAM111A	386	Q96PZ2
VGDGIEPSKWATIIG	FAM111A	391	Q96PZ2
VGVGKVIRGWDEALL	FKBP3	166	Q00688
PKAEDLRVGLISWAG	FSCN3	11	Q9NQT6
ASGIVEFWVDGKPRV	CRP	121	P02741
KEELLKVAGSPGWVR	SLC3A2	166	P08195
VRQAPGKGLEWVSAI	IGHV3-23	56	P01764
VRQAPGKGLEWVAVI	IGHV3-30	56	P01768
IWEKANLTLPRGIGE	ASNSD1	566	Q9NWL6
VIPVLGEVIAGDWKS	COQ5	266	Q5HYK3
EVRLAGGVWRVISKP	CCDC8	16	Q9H0W5
ILKEANWLVAGPGAE	SLC38A10	906	Q9HBR0
PLGRVLGVWIAVEDA	PHYHD1	166	Q5SRE7
PVGVFIIERETGWLK	CDH1	201	P12830
KGRIIPGADADVVVW	DPYSL5	391	Q9BPU6
GLAIWDRALVPGEVA	PTX4	426	Q96A99
VRGGPLQEEEIWAVL	PTPN13	11	Q12923
VRQAPGKGLEWVAVI	IGHV3-33	56	P01772
VRQAPGKGLEWVSVI	IGHV3-53	56	P01767
PGRVVDIRGWDVETG	MIB2	181	Q96AX9
IIRGWAEKIPGFADL	NR4A2	416	P43354
PWREDEICVVGIFGK	SMG8	41	Q8ND04
EVPEWLREGEFVTVG	KIF13B	1696	Q9NQT8
AEWREEGKAEIIPGV	RUVBL2	281	Q9Y230
RPLWRDIVEGGSEKA	SYT3	416	Q9BQG1
ESVRNGWKPVGDLLI	UTRN	2711	P46939
DRPGVVGIWLNLEEG	RNF135	371	Q8IUD6
KLRAAGVGDRPVVWI	SERAC1	481	Q96JX3
RAPVDITGQFEKWGE	CARS1	471	P49589
EAGDAVVAKPGVWAR	TIMM29	16	Q9BSF4
LESKWPIVVAEGEGQ	TMEM132B	741	Q14DG7
VIWPDGKRVVLLAEG	AHCYL1	426	O43865
PELVEVIRRLWKDGG	GNAT2	121	P19087
FWGRDKNVPTIGVIA	ST3GAL5	331	Q9UNP4
AVRWVGGPEIELIAI	CCT5	321	P48643
WEAGKFGNEVIPVTV	ACAT1	226	P24752
GQEWIVVVCPVGKRA	SNUPN	116	O95149
ATPLEDVGKQVWRGA	METTL22	176	Q9BUU2
LWDEEVARVGPEKAS	ABCC12	96	Q96J65
VDVEAPGAKLDGAWL	AHNAK2	2451	Q8IVF2
IGPWIQAKVEEVGRL	ACTN3	656	Q08043
EWLKVIREVSKPVGG	AFAP1L1	306	Q8TED9
WGVAYRLPVGKEEEV	CHAC2	61	Q8WUX2
VPAGVGAAIELWKVK	CLPTM1L	351	Q96KA5
LVEPDVSRLGWGVVK	CLEC16A	736	Q2KHT3
LGEGAVKRPLDVDWT	C15orf39	146	Q6ZRI6
GVPDEEGWVKVTRRG	RRP7A	196	Q9Y3A4
VPDEEGWVKVTRRGR	RRP7BP	21	Q9NSQ0
VPGRWAFKVDGKEID	TECTA	241	O75443
AVGVEKNWGAVVRSP	ZC3HC1	11	Q86WB0
DPKVRAGAVDVVRHW	PITPNM1	1041	O00562
LENGKGPWVTVREIS	ZNF624	106	Q9P2J8
AVPVKVTDRFGIWTG	ZCCHC3	281	Q9NUD5
VKLWDPVDGSVVRDF	WDR88	126	Q6ZMY6
IGRSLPEAEWKEVAG	ZFHX2	741	Q9C0A1
WLGGGVVPDAIVLAE	RBP3	606	P10745
GGRDGTVRVWKIPEE	RRP9	301	O43818
RVLGRKTPWGIIEVE	SEPTIN3	276	Q9UH03
AELVPGVAELEGKGW	PRX	1036	Q9BXM0
PEWVVKESGILVLGA	TNPO2	406	O14787
LEEVWDCVKPAVGGL	STARD5	61	Q9NSY2
GTEGPFVERVTAVWK	GEMIN5	1151	Q8TEQ6
EVVGKGWPFSAVTVE	MYCBPAP	356	Q8TBZ2
EGPGVDLAAKAQVWL	NAPRT	236	Q6XQN6
WVGELTNGRHEIVPK	PSMA3	216	P25788
VGDKPRWALGVIAAE	TRIM72	351	Q6ZMU5
AVRWEKLEGQGDVPT	SUGT1	251	Q9Y2Z0
GGVFKVEWIRKESLP	YTHDC2	1366	Q9H6S0
KGELRLRPEEGVWAV	TRIM10	391	Q9UDY6
FLWIEEPGGVIVGKS	VSIG10	256	Q8N0Z9
VGKILAALPVDWRGT	SLC29A4	401	Q7RTT9
ATQVPEGAAKWGLVA	PIEZO1	771	Q92508
GWRAPGAEAAVEVLA	TARBP1	131	Q13395
VMVGWVDKDLAPGIA	POLR1B	561	Q9H9Y6
AVVPREIKGKGGVWR	PNMA8C	81	A0A1B0GUJ8
FGIPKWAREKIVNGI	TMEM145	371	Q8NBT3
GLEPRAVVEHTGKLW	VWA5B1	1131	Q5TIE3
GWVEVRDVIIHRVGP	NALCN	1116	Q8IZF0
EVGTFKERIQWVGDP	MPZ	91	P25189
GIIVDLKVWRTDPGS	NEBL	836	O76041
GIGWVPIGSVEVEKV	NEB	3636	P20929